One recent study demonstrated that a HER2-targeted aptamer can differentiate both HER2-positive breast cancer cells and xenografted mice models from other subtypes of breast cancer through fluorescence imaging (Liu et al., 2018). Here, ERBB2 is linked to breast carcinoma.